Home > Healthcare > Medical Devices > Diagnostic Devices > Self-testing Market

Self-testing Market Trends

Report ID: GMI7669
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Self-testing Market Trends

Technological advancements have led to the development of self-test kits with improved accuracy and reliability. Advanced biosensors, diagnostic technologies, and algorithms contribute to more precise test results, increasing confidence among users.

Advance and modern self-test kits integrate seamlessly with digital health platforms and mobile applications. This integration allows users to track and monitor their test results digitally, providing a more comprehensive and accessible overview of their health status.
For instance, in October 2023, PHASE Scientific Americas, a global biomedical company focusing on offering innovative healthcare diagnostics solutions launched INDICAID health, company's at-home health tests and digital health experiences. After obtaining the test results, the users can get required guidance or treatment advise through company's virtual platform. Such developments will further boost the product adoption rate.
Some self-test kits enable multiple testing, allowing a single self-test kit to assess multiple health parameters simultaneously. This enhances the efficiency of testing and provides a more comprehensive health profile.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Self-testing industry size was USD 15 billion in 2023 and is estimated to reach over USD 27.2 billion by 2032 due to the rise in chronic diseases and the rapidly aging population.

Self-testing industry size from the kits product type segment was valued at USD 6.4 billion in 2023 owing to their growing adoption to cater to a wide range of tests and health parameters.

North America self-testing industry size was USD 4.8 billion in 2023 and is predicted to witness substantial growth up to 2032 owing to the growing emphasis on consumer empowerment in healthcare.

Few of the major self-testing firms include F. Hoffmann-La Roche Ltd., Piramal Enterprises Ltd., Becton, Dickinson and Company, PRIMA Lab SA, B. Braun Melsungen AG, Alere Inc., Cardinal Health, and Quidel Corporation.